On January 31, A-share listed Daan Gene released the 2022 full-year performance forecast. Read More >

Precision oncology company Guardant Health announced on Monday that FDA has approved its Guardant360 CDx liquid biopsy test as a companion diagnostic.... Read More >

SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2022. ... Read More >

Easy Diagnosis released a performance preview on the evening of January 30, expecting 2022 net profit attributable to shareholders of listed companies of CNY4.6 billion to CNY5 billion, an increase of 225.5% to 253.8%; basic earnings per share of about CNY29.99 to CNY32.60. ... Read More >

GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, reported financial results for the fourth quarter and full year ended December 31, 2022.... Read More >

Danaher Corporation (NYSE: DHR) (the "Company") announced results for the fourth quarter and full year 2022. All results in this release reflect only continuing operations unless otherwise noted. Net earnings refers to net earnings attributable to common shareholders. ... Read More >

On the evening of January 19, Andon Health Co., Ltd. released the 2022 performance forecast, and it is expected that the company's net profit in 2022 will be 16.5 billion CNY to 17.5 billion CNY, a year-on-year increase of 1715.9% to 1825.95%.... Read More >

Johnson & Johnson announced results for fourth-quarter and full year 2022. Read More >

Abbott announced financial results for the fourth quarter ended Dec. 31, 2022. Read More >

VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. Read More >